BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 17955968)

  • 1. Stability Indicating RP-HPLC Method for Simultaneous Determination of Simvastatin and Ezetimibe from Tablet Dosage Form.
    Dixit RP; Barhate CR; Padhye SG; Viswanathan CL; Nagarsenker MS
    Indian J Pharm Sci; 2010 Mar; 72(2):204-10. PubMed ID: 20838524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Validation of a Stability-indicating UPLC-DAD Method for the Simultaneous Determination of Ivermectin and Praziquantel in Pharmaceutical Tablets and Dissolution Media.
    Ibrahim A; Wang F; Gary Hollenbeck R; Martinez MN; Fahmy R; Hoag SW
    AAPS PharmSciTech; 2023 Oct; 24(7):211. PubMed ID: 37821763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of Drospirenone- and Ethinyl Estradiol-Related Impurities in a Combined Pharmaceutical Dosage Form by a Chromatography Method With a QbD Robustness Study.
    Chinta SR; Chintala V; Nandimalla V; Ch R; Ediga SG; Kowtharapu LP; Katari NK
    J AOAC Int; 2024 Jan; 107(1):31-39. PubMed ID: 37758265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a sustainable multianalyte MEKC method for quantitation of the antihyperlipidemic drugs ezetimibe together with three statins. Greenness and whiteness appraisal studies.
    Elbordiny HS; Elonsy SM; Daabees HG; Belal TS
    BMC Chem; 2023 Sep; 17(1):124. PubMed ID: 37742031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a novel quality by design-enabled stability-indicating HPLC method and its validation for the quantification of nirmatrelvir in bulk and pharmaceutical dosage forms.
    Alegete P; Byreddy S
    Biomed Chromatogr; 2024 Mar; 38(3):e5812. PubMed ID: 38228470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous determination of praziquantel, fipronil, eprinomectin, (S)-methoprene, their key related substances and butylated hydroxytoluene (BHT) in a topical veterinary drug product by a single stability indicating high performance liquid chromatography method.
    Rathnasekara RP; Rustum AM
    J Pharm Biomed Anal; 2024 Jan; 238():115805. PubMed ID: 37948779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of HPLC Method for Ixabepilone (Oncology Drug) in Bulk and Dosage Form: Quantification of Impurities and Forced Degradation Studies.
    Nekkalapudi AR; Navuluri S; Pippalla S; Katari NK; Cholleti VK; Bapatu HR
    J Chromatogr Sci; 2024 Mar; 62(3):222-231. PubMed ID: 37465887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Empagliflozin: Validation of Stability-Indicating LC Method and in silico Toxicity Studies.
    da Silva AT; Brabo GR; Porto DDS; da Silva Jonco J; Bajerski L; Paula FR; Paim CS
    J Chromatogr Sci; 2024 Feb; 62(2):132-139. PubMed ID: 36585772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Validation of Stability-Indicating High-Performance Liquid Chromatography Method for Estimation of Lacosamide in Bulk and Its Pharmaceutical Dosage Form.
    Padhiyar S; Jivani KM; Upadhyay J; Patel T; Suhagia B
    J Chromatogr Sci; 2023 Dec; 61(10):943-952. PubMed ID: 36465018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delapril and Indapamide: Development and Validation of a Stability-Indicating Core-Shell LC Method and Its Application for Simultaneous Tablets Assay.
    Gonçalves BR; Machado AKMS; Oliveira PR; Barth T; Sangoi MS; Todeschini V
    J AOAC Int; 2018 Jul; ():. PubMed ID: 29996962
    [No Abstract]   [Full Text] [Related]  

  • 11. Stability-indicating normal-phase HPLC method development for separation and quantitative estimation of S-enantiomer of lacosamide in pharmaceutical drug substance and tablet dosage form.
    Vadagam N; Haridasyam SB; Venkatanarayana M
    Biomed Chromatogr; 2023 Sep; 37(9):e5688. PubMed ID: 37325866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Green micellar liquid chromatographic method for simultaneous determination of antihistaminic drugs tripelennamine hydrochloride and diphenhydramine in pharmaceutical gel.
    Hammad SF; El-Malla SF; El-Khateeb BZ
    J Sep Sci; 2024 Jan; 47(2):e2300757. PubMed ID: 38286731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Reversed-Phase UPLC Method for Assay of Fipronil Including Determination of Its Related Substances in Bulk Batches of Fipronil Drug Substance.
    Berger SN; Rustum AM
    J AOAC Int; 2024 Mar; ():. PubMed ID: 38532305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality Control of L-Ascorbic Acid 2-Phosphate Magnesium Using Reversed-Phase Liquid Chromatography.
    Wynendaele E; Urlaub J; Xu X; Holzgrabe U; De Spiegeleer B
    J Chromatogr Sci; 2024 May; ():. PubMed ID: 38796178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability-indicating RP-HPLC Method for the Simultaneous Determination of Sitagliptin and Simvastatin in Tablets.
    Ramalingam P; Bhaskar VU; Reddy YP; Kumar KV
    Indian J Pharm Sci; 2014 Sep; 76(5):407-14. PubMed ID: 25425754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability-indicating reversed-phase liquid chromatographic method for simultaneous determination of simvastatin and ezetimibe from their combination drug products.
    Chaudhari BG; Patel NM; Shah PB
    J AOAC Int; 2007; 90(5):1242-9. PubMed ID: 17955968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability-indicating reversed-phase liquid chromatographic method for simultaneous determination of atorvastatin and ezetimibe from their combination drug products.
    Chaudhari BG; Patel NM; Shah PB; Patel LJ; Patel VP
    J AOAC Int; 2007; 90(6):1539-46. PubMed ID: 18193730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid and sensitive simultaneous determination of ezetimibe and simvastatin from their combination drug products by monolithic silica high-performance liquid chromatographic column.
    Hefnawy M; Al-Omar M; Julkhuf S
    J Pharm Biomed Anal; 2009 Oct; 50(3):527-34. PubMed ID: 19487095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous liquid chromatographic determination of ezetimibe and simvastatin in pharmaceutical products.
    Oliveira PR; Barth T; Todeschini V; Dalmora SL
    J AOAC Int; 2007; 90(6):1566-72. PubMed ID: 18193733
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.